Danone has signed a deal to buy the nutrition unit of India’s Wockhardt Group, days after reports that the companies were in talks.

The deal, announced today (2 August), will see Danone acquire Wockhardt’s nutrition business and brands as well as related industrial operations from the Indian firm’s subsidiary Carol Info Service. The transaction is valued at EUR250m (US$354.7m).

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The acquisition will allow Danone to enter the baby nutrition and medical nutrition markets in India, as well as provide the company with access to a distribution network across the country.

Wockhardt’s brands include Dexolac, Farex and Nusobee baby nutrition products. In addition, the nutritional supplement brand Protinex will give Danone “a strong foundation” for developing its medical nutrition business, the French firm said.

The sale will allow Wockhardt to focus on its pharmaceutical operations, it explained. “Wockhardt continues to be on the growth track and the strategy to consolidate and rationalise all its core operations is showing encouraging results. Wockhardt is re-inventing itself by taking fundamentally strong and positive steps with a firm focus on its core human pharmaceutical business,” the Indian company said.

The closing of the transaction is subject to certain terms and conditions of the agreement.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The deal comes over a year after Wockhardt and US-based healthcare group Abbott Laboratories ended talks over the business.

In June 2009, Wockhardt agreed to sell its nutrition business to Abbott but, by April the following year, both companies had announced that talks had been called off. Reports in India said pressure from Wockhardt’s lenders had ended the deal.